Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
09/16/1998 | EP0863992A1 Product and process to regulate actin polymerization |
09/16/1998 | EP0863991A1 Antigenic preparations |
09/16/1998 | EP0863988A1 Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome |
09/16/1998 | EP0863986A1 Transferrin binding proteins of pasteurella haemolytica and vacc ines containing same |
09/16/1998 | EP0863984A1 Methods and compositions for the diagnosis and treatment of cancer |
09/16/1998 | EP0863981A1 Detection, prevention and treatment of papillomatous digital dermatitis |
09/16/1998 | EP0863918A1 Method for control of functionality during cross-linking of hemoglobins |
09/16/1998 | EP0863917A1 Targeted cytotoxic anthracycline analogs |
09/16/1998 | EP0863916A1 Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
09/16/1998 | EP0863915A1 ACYLATED ENOL DERIVATIVES OF $g(a)-KETOESTERS AND $g(a)-KETOAMIDES |
09/16/1998 | EP0863914A1 Tetracyclic triterpenes as cholesterol-lowering and anti-atherosclerosis agents |
09/16/1998 | EP0863913A1 A method to increase the density of antigen on antigen presenting cells |
09/16/1998 | EP0863911A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
09/16/1998 | EP0863907A1 Cycloanthelmintic inhibitors |
09/16/1998 | EP0863905A1 Novel imidazole lipoxygenase inhibitors |
09/16/1998 | EP0863904A2 Novel spiro 2h-1-benzopyran-2,4'-piperidine]- 4(3h)-one derivatives, acid addition salts thereof and pharmaceutical compositions containing them |
09/16/1998 | EP0863903A1 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
09/16/1998 | EP0863902A1 2'- 4'-HALO- 1,1'-BIPHENYL]-4-YL]METHYL]-5'-METHYL-SPIRO CYCLOPENTANE-1,7'(8'H)- 3H]IMIDAZO 2,1-b]PURIN]-4'(5'H)-ONES |
09/16/1998 | EP0863901A1 Carbapenem antibiotic, composition and method of preparation |
09/16/1998 | EP0863899A1 Pyridopyrimidines |
09/16/1998 | EP0863897A1 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one derivatives for use as 5-ht 4? or h 3? receptor ligands |
09/16/1998 | EP0863896A1 Novel imidazole derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists |
09/16/1998 | EP0863893A1 Fibrinogen receptor antagonist |
09/16/1998 | EP0863892A1 Lipophilic benzothiophenes |
09/16/1998 | EP0863891A1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors |
09/16/1998 | EP0863890A1 5-amidomethyl alpha, betha-saturated and -unsaturated 3-aryl butyrolactone antibacterial agents |
09/16/1998 | EP0863887A1 Intermediary compounds for the hemisynthesis of taxanes and preparation processes therefor |
09/16/1998 | EP0863885A2 Novel macrocyclic compounds as metalloprotease inhibitors |
09/16/1998 | EP0863883A1 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
09/16/1998 | EP0863882A1 Amino substituted pyrimidines and triazines |
09/16/1998 | EP0863881A1 Benzimidazole derivatives and their use in the prevention and/or the treatment of bone diseases |
09/16/1998 | EP0863880A1 Novel 1-ar(alk)yl-imidazolin-2-ones containing a disubstituted amine radical in the 4th position, having an anti-convulsive effect, and process for their production |
09/16/1998 | EP0863878A1 Cyclic nitrones and pharmaceutical compositions containing them |
09/16/1998 | EP0863876A1 Quinoline derivatives containing a diol as leukotriene antagonists |
09/16/1998 | EP0863875A1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
09/16/1998 | EP0863873A1 Indole carbamates as leukotriene antagonists |
09/16/1998 | EP0863870A1 Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents |
09/16/1998 | EP0863866A1 Butyrate prodrugs of lactic acid |
09/16/1998 | EP0863769A1 Glycoconjugates as virus cell adhesion inhibitors |
09/16/1998 | EP0863768A2 Glycosaminoglycan-antithrombin iii/heparin cofactor ii conjugates |
09/16/1998 | EP0863767A2 Powdery iodine complexes |
09/16/1998 | EP0863766A1 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product |
09/16/1998 | EP0863765A1 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
09/16/1998 | EP0863761A1 Topical compositions containing a beta-cyclodextrin and an amino polysaccharide |
09/16/1998 | EP0863760A1 Use of antimineralocorticoid compounds against drug withdrawal syndrome |
09/16/1998 | EP0863759A1 Use of a combination of pentoxifylline and type i interferons for treating multiple sclerosis |
09/16/1998 | EP0863758A1 Composition containing mefenamic acid in association with codeine |
09/16/1998 | EP0863757A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
09/16/1998 | EP0863756A1 Use of 2-iminobenzothiazolines for treating parkinson's disease and parkinsonian syndromes |
09/16/1998 | EP0863755A1 Antithrombotic diamines |
09/16/1998 | EP0863754A1 Hydrolysis-optimized lipid emulsions and use thereof |
09/16/1998 | EP0863753A1 Perfluoroalkyl substituted metallo-beta-lactamase inhibitors and method for the preparation of trifluoromethylketone derivatives |
09/16/1998 | EP0863752A1 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases |
09/16/1998 | EP0863751A2 Improved method for preventing crystal formation in a dispersion of a liquid in a matrix |
09/16/1998 | EP0863749A2 Complex cationic lipids |
09/16/1998 | EP0863747A1 Stimulation of hair follicles |
09/16/1998 | EP0863744A2 Lipoic acid in topical compositions |
09/16/1998 | EP0863743A1 Skin care preparation and method |
09/16/1998 | EP0863741A2 Reduction of hair growth |
09/16/1998 | EP0863740A1 Reduction of hair growth |
09/16/1998 | EP0863729A1 Implantable controlled release device to deliver drugs directly to an internal portion of the body |
09/16/1998 | EP0863704A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
09/16/1998 | EP0833629A4 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
09/16/1998 | EP0810854A4 Aerosols containing beclomethazone nanoparticle dispersions |
09/16/1998 | EP0767786B1 7-ether-taxol analogs, antineoplastic use and pharmaceutical compositions containing them |
09/16/1998 | EP0756598B1 Substituted 5,6-dihydro-5-oxo-1,4-dithiino-(2,3-d)-pyridazine-2,3-dicarbonitriles, compositions containing them and their use as antimicrobials |
09/16/1998 | EP0733047B1 Substituted oxazolidines with stimulating effect of beta-adrenergig receptor |
09/16/1998 | EP0728128B1 Substituted phenyl compounds |
09/16/1998 | EP0710230B1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
09/16/1998 | EP0708640B1 Pharmaceutical preparations with an active principle containing modified amidin groups |
09/16/1998 | EP0707586B1 Positive inotropic and lusitropic pyrroloquinolinone derivatives |
09/16/1998 | EP0700291B1 15-substituted 4-azasteroids |
09/16/1998 | EP0661930B1 Viscous liquid xylitol compositions and method for preparing same |
09/16/1998 | EP0654023B1 5-(2-oxyphenyl)-pyrrole derivatives as dopamine d3 receptor antagonists |
09/16/1998 | EP0650496B1 Anti-inflammatory compounds for ophthalmic use |
09/16/1998 | EP0624162B1 Novel steroid intermediates and processes for their preparation |
09/16/1998 | EP0577602B1 Transdermal contraceptive formulations, methods and devices |
09/16/1998 | EP0570380B1 Novel methylenebisphosphonic acid derivatives |
09/16/1998 | EP0530265B1 Dna encoding human 5-ht 1d receptors and uses thereof |
09/16/1998 | EP0520032B1 Use of spiperone as an immunosuppressant and anti-inflammatory agent |
09/16/1998 | CN1193353A Allergen-XCD32 fusion proteins |
09/16/1998 | CN1193350A Antigen non-specific glycosylation inhibiting factor derivatives |
09/16/1998 | CN1193325A Cell adhension inhibitors |
09/16/1998 | CN1193315A Bicyclic amino derivatives and PGDZ antagonist containing same |
09/16/1998 | CN1193313A Propynyl or dienyl diaromatic compounds |
09/16/1998 | CN1193280A Control of CD44 gene expression for therapeutic use |
09/16/1998 | CN1193278A Chemical compounds |
09/16/1998 | CN1193277A Antiviral agents |
09/16/1998 | CN1193276A Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
09/16/1998 | CN1193275A Percutaneous tap preparation containing fentanyl |
09/16/1998 | CN1193274A Calcium-ion channel antagonists |
09/16/1998 | CN1193023A Indocalamus-leaf polyose sulfate and preparation process therefor |
09/16/1998 | CN1193022A Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist |
09/16/1998 | CN1193021A Intermediate compound for synthesizing nucleoside derivative |
09/16/1998 | CN1193019A Effective components of wild opium poppy and extracting process and product thereof |
09/16/1998 | CN1193017A Sulfamide-substituted condensed seven-membered ring chemical compound, use as medicine and medicinal preparation containing same |
09/16/1998 | CN1193013A Modified oligodeoxynucleotide acid |
09/16/1998 | CN1193012A Sulfamine-substituted chemical compound, preparing process therefor, and use as medicine and diagnosis agent and medicine containing same |
09/16/1998 | CN1192904A Composite preparation for treatment of dementia |
09/16/1998 | CN1192903A Medicine of diguanidino-prine-hydride compounds for giving up drug-taking |